Foley & Lardner Awarded Gold Standard Certification by WILEF for Promoting Gender Diversity

12 July 2021 Media Contact: Rachel Sisserson News
WILEF Seal

The Women in Law Empowerment Forum (WILEF) has awarded Foley & Lardner its 2021 Gold Standard Certification for its commitment to promoting gender diversity. WILEF grants Gold Standard status to major firms that meet objective criteria concerning the number of women among equity partners, in firm leadership positions, and in the ranks of their most highly compensated partners.

For 2021 US Gold Standard Certification, new criteria meant that firms had to satisfy both of the following two mandatory criteria:

  • 25% of equity partners or, alternatively, 40% of the attorneys becoming equity partners during the past 12 months are women
  • 10% of women equity partners are women of color or 4% of women equity partners are LGBT

and at least two of the following four criteria:

  • 20% of the firm and U.S. branch office heads are women
  • 25% of the firm’s primary governance committee are women
  • 25% of the firm’s compensation committee or its equivalent are women
  • 20% of the top half of the firm’s equity partners in terms of compensation are women

Launched in 2007, WILEF is the premier organization for women in law exclusively dedicated to women from the largest law firms and corporate law departments in the United States.

Insights

Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
End In Sight for Auto Shortage? Not So Fast
29 July 2021
Dashboard Insights
Legal Updates: Proposed Legislation for Private Foundation Minimum Distribution Requirements
28 July 2021
Legal News: Family Offices
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream